Use of CA15-3 for screening breast cancer: An antibody-lectin sandwich assay for detecting glycosylation of CA15-3 in sera

Elevated serum CA15-3 assessed by enzyme-linked immunosorbent assay (ELISA) has been considered a diagnostic marker of breast cancer. However, accumulating data indicate that the current ELISA system for detecting CA15-3, which targets the peptide backbone of CA15-3, is not sufficiently sensitive to...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jae Woong, Moon, Byung-In, Lee, Jun Woo, Kim, Hyoung Jin, Jin, Yingji, Kim, Hong-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059737/
https://www.ncbi.nlm.nih.gov/pubmed/29749490
http://dx.doi.org/10.3892/or.2018.6433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059737/
https://www.ncbi.nlm.nih.gov/pubmed/29749490
http://dx.doi.org/10.3892/or.2018.6433

Ejemplares similares